Citation 143775

SAKAGAMI,H: JIANG,Y: KUSAMA,K: ATSUMI,T: UEHA,T: TOGUCHI,M: IWAKURA,I: SATOH,K: FUKAI,T: NOMURA,T:. (2000). INDUCTION OF APOPTOSIS BY FLAVONES, FLAVONOLS (3-HYDROXYFLAVONES) AND ISOPRENOIDS-SUBSTITUTED FLAVONOIDS IN HUMAN ORAL TUMOR CELL LINES.. 20(1A)

Citation Details

Title	INDUCTION OF APOPTOSIS BY FLAVONES, FLAVONOLS (3-HYDROXYFLAVONES) AND ISOPRENOIDS-SUBSTITUTED FLAVONOIDS IN HUMAN ORAL TUMOR CELL LINES.
Authors	SAKAGAMI,H: JIANG,Y: KUSAMA,K: ATSUMI,T: UEHA,T: TOGUCHI,M: IWAKURA,I: SATOH,K: FUKAI,T: NOMURA,T:
Year	2000
Volume	20
Issue	1A

Summary

Year: 2000

Journal: Unknown

Organisms and Their Experiments (1)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	APIGENIN	INACTIVE
2	VERMIFUGE ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	APIGENIN	INACTIVE
3	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	APIGENIN	INACTIVE
4	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CHRYSIN	INACTIVE
5	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CHRYSIN	INACTIVE
6	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CHRYSIN	INACTIVE
7	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ARTOCARPETIN,NOR:	EQUIVOCAL
8	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ARTOCARPETIN,NOR:	INACTIVE
9	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ARTOCARPETIN,NOR:	INACTIVE
10	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	KAEMPFEROL	INACTIVE
11	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	KAEMPFEROL	INACTIVE
12	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	KAEMPFEROL	INACTIVE
13	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	MORIN	INACTIVE
14	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	MORIN	INACTIVE
15	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	MORIN	INACTIVE
16	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	KUMATAKENIN	INACTIVE
17	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	KUMATAKENIN	INACTIVE
18	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	KUMATAKENIN	INACTIVE
19	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	MORUSIN	WEAK ACTIVITY
20	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	MORUSIN	WEAK ACTIVITY
21	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	MORUSIN	WEAK ACTIVITY
22	APOPTOSIS INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	MORUSIN	ACTIVE
23	APOPTOSIS INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	MORUSIN	ACTIVE
24	APOPTOSIS INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	MORUSIN	ACTIVE
25	APOPTOSIS INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	MORUSIN	ACTIVE
26	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ARTONIN E	WEAK ACTIVITY
27	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ARTONIN E	WEAK ACTIVITY
28	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ARTONIN E	WEAK ACTIVITY
29	APOPTOSIS INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	ARTONIN E	ACTIVE
30	APOPTOSIS INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	ARTONIN E	ACTIVE
31	APOPTOSIS INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	ARTONIN E	ACTIVE
32	APOPTOSIS INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	ARTONIN E	ACTIVE
33	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CYCLOMORUSIN	EQUIVOCAL
34	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CYCLOMORUSIN	INACTIVE
35	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CYCLOMORUSIN	INACTIVE
36	APOPTOSIS INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	CYCLOMORUSIN	ACTIVE
37	APOPTOSIS INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	CYCLOMORUSIN	ACTIVE
38	APOPTOSIS INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	CYCLOMORUSIN	ACTIVE
39	APOPTOSIS INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	CYCLOMORUSIN	ACTIVE
40	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	IKARISOSIDE E	EQUIVOCAL
41	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	IKARISOSIDE E	WEAK ACTIVITY
42	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	IKARISOSIDE E	EQUIVOCAL
43	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	KUWANON C	WEAK ACTIVITY
44	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	KUWANON C	INACTIVE
45	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	KUWANON C	WEAK ACTIVITY
46	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	KUWANON S	EQUIVOCAL
47	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	KUWANON S	INACTIVE
48	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	KUWANON S	EQUIVOCAL
49	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	KUWANON G	INACTIVE
50	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	KUWANON G	INACTIVE
51	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	KUWANON G	INACTIVE
52	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	KUWANON M	WEAK ACTIVITY
53	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	KUWANON M	WEAK ACTIVITY
54	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	KUWANON M	INACTIVE
55	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ALBANIN D	WEAK ACTIVITY
56	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ALBANIN D	EQUIVOCAL
57	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ALBANIN D	WEAK ACTIVITY
58	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GANCAONIN O	WEAK ACTIVITY
59	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GANCAONIN O	EQUIVOCAL
60	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GANCAONIN O	EQUIVOCAL
61	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GLYASPERIN A	WEAK ACTIVITY
62	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GLYASPERIN A	WEAK ACTIVITY
63	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GLYASPERIN A	WEAK ACTIVITY
64	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	LICOFLAVONOL	WEAK ACTIVITY
65	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	LICOFLAVONOL	INACTIVE
66	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	LICOFLAVONOL	EQUIVOCAL
67	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	TOPAZOLIN	WEAK ACTIVITY
68	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	TOPAZOLIN	WEAK ACTIVITY
69	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	TOPAZOLIN	INACTIVE
70	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GANCAONIN P	WEAK ACTIVITY
71	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GANCAONIN P	EQUIVOCAL
72	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GANCAONIN P	EQUIVOCAL
73	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BROUSSOFLAVONOL B	WEAK ACTIVITY
74	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BROUSSOFLAVONOL B	WEAK ACTIVITY
75	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BROUSSOFLAVONOL B	WEAK ACTIVITY
76	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BROUSSOFLAVONOL E	WEAK ACTIVITY
77	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BROUSSOFLAVONOL E	WEAK ACTIVITY
78	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BROUSSOFLAVONOL E	WEAK ACTIVITY
79	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BROUSSOFLAVONOL C	WEAK ACTIVITY
80	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BROUSSOFLAVONOL C	WEAK ACTIVITY
81	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BROUSSOFLAVONOL C	WEAK ACTIVITY
82	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	IKARISOSIDE A	EQUIVOCAL
83	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	IKARISOSIDE A	EQUIVOCAL
84	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	IKARISOSIDE A	EQUIVOCAL
85	APOPTOSIS INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	GALLIC ACID	ACTIVE
86	APOPTOSIS INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	GALLIC ACID	INACTIVE
87	APOPTOSIS INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	GALLIC ACID	ACTIVE
88	APOPTOSIS INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	GALLIC ACID	INACTIVE

Citation 143775

Citation Details

Summary

Organisms and Their Experiments (1)

Unknown organism

Show SPARQL Queries (1)

Query 1